FDA Inspection 700863 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 3005680856

The FDA completed an inspection of New York Blood Center Enterprises on December 9, 2010 in Port Jefferson Station, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 9, 2010
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Port Jefferson Station, NY (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs